More Orthocell Ltd news Orthocell LtdASX: OCC 10th Patient Treatment Milestone in Human Tendon Study May 17, 2018 at 12:17 AM EDT · Issued by Orthocell Ltd Filed with ASX · May 17, 2018 at 12:17 AM EDTOn 6ix: 6ix.com/news/10th-patient-treatment-milestone-in-human-tendon-studyOrthocell Ltd has released a press release. View Attachment6ix hasn’t read this filing yet. Read this filing Orthocell Ltd on 6ix Story so far50% Patient Treatment Milestone in Human Nerve TrialJan 2, 2018Early Positive Results for CelGro in Human Tendon StudyJun 16, 2016Approval for Human Tendon Study Using Celgro ReceivedMar 30, 2016 Earlier from OrthocellOrthocell Extends Distributor Network in the EUMay 7, 2018Orthocell Announces Successful Bone Repair Study ResultsApr 30, 2018Orthocell Appoints First Distributor in the EUApr 29, 2018New Cell Factory Patent Granted in the USFeb 21, 2018Positive CelGro Study Results in ACL ReconstructionFeb 4, 2018Later from OrthocellFirst Product Use and Sale of CelGro in EuropeMay 21, 2018Orthocell Secures CelGro Patent Protection in EuropeMay 24, 2018First Product Use and Sales of CelGro in PolandMay 30, 2018Orthocell Announces Successful Tendon Study ResultsJun 6, 2018Orthocell Announces Successful Ortho-ATI Study ResultsJun 13, 2018All Orthocell news releases↗Follow Orthocell into a list and get an email when it puts out news.Follow Orthocell